IL-1β suppresses anti-tumor immune responses by promoting Tregs, IL-6 promotes tumor growth and metastasis while inhibiting anti-tumor immunity, and IFN-γ activates CD8+ cytotoxic T lymphocytes, enhancing their tumor-killing ability [36–38]. This evidence concerns the gene CD8A and neoplasm.